A UVA doctor explains how these treatments were helping bring down hospitalized COVID-19 patient mortality rates before the delta variant hit and are continuing to improve patient outcomes today.
At question is the role of osteoclasts, which cause bone degradation 鈥 but also stimulate normal bone regrowth. Researchers are searching for ways to slow their work without eliminating them.